A61P 31/00
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/00 (Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics) appears on 61,665 US grants and 88,409 published applications in this corpus.
Search patents in A61P- Granted patents
- 61,665
- Published applications
- 88,409
- Assignees
- 20,028
- Inventors
- 125,159
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 61 | 0 |
| 1977 | 98 | 0 |
| 1978 | 145 | 0 |
| 1979 | 124 | 0 |
| 1980 | 200 | 0 |
| 1981 | 213 | 0 |
| 1982 | 189 | 0 |
| 1983 | 171 | 0 |
| 1984 | 205 | 0 |
| 1985 | 207 | 0 |
| 1986 | 167 | 0 |
| 1987 | 182 | 0 |
| 1988 | 196 | 0 |
| 1989 | 265 | 0 |
| 1990 | 267 | 0 |
| 1991 | 263 | 0 |
| 1992 | 283 | 0 |
| 1993 | 201 | 0 |
| 1994 | 242 | 0 |
| 1995 | 364 | 0 |
| 1996 | 503 | 0 |
| 1997 | 749 | 0 |
| 1998 | 939 | 0 |
| 1999 | 1174 | 0 |
| 2000 | 1197 | 0 |
| 2001 | 1341 | 341 |
| 2002 | 1314 | 1654 |
| 2003 | 1346 | 2743 |
| 2004 | 1018 | 3290 |
| 2005 | 953 | 3310 |
| 2006 | 1398 | 3173 |
| 2007 | 1370 | 3337 |
| 2008 | 1491 | 3975 |
| 2009 | 1742 | 4513 |
| 2010 | 2370 | 5360 |
| 2011 | 2464 | 5111 |
| 2012 | 3046 | 4989 |
| 2013 | 3216 | 3806 |
| 2014 | 3511 | 3915 |
| 2015 | 3011 | 3662 |
| 2016 | 2788 | 3605 |
| 2017 | 2848 | 3409 |
| 2018 | 2520 | 3439 |
| 2019 | 2561 | 3588 |
| 2020 | 2409 | 3252 |
| 2021 | 2260 | 3294 |
| 2022 | 1904 | 3295 |
| 2023 | 1622 | 3894 |
| 2024 | 1900 | 3325 |
| 2025 | 1632 | 2560 |
| 2026 | 1025 | 1569 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Engineered cells and uses thereof6 Oct 2026US 12,751,929 B2Ohio State Innovation Foundation
- Methods of treating influenza and poxvirus viral infections6 Oct 2026US 12,751,942 B2Veru Inc.
- Methods and compositions for treating fungal infections6 Oct 2026US 12,751,944 B2Neoculi Pty Ltd
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- Bacteriophage effective for controlling Salmonella typhimurium and its derived biofilm, and an antibacterial composition comprising the same6 Oct 2026US 12,751,982 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Cosmetic composition comprising an endolysin and an organic filler8 Oct 2026US 2026/0306385 A1L'oreal
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Materials and methods for treating fungal infections8 Oct 2026US 2026/0306425 A1Virginia Tech Intellectual Properties, Inc.
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
- Halogenated Xanthene-Containing Topical Anti-Gram-Positive Bacterial Ophthalmic Composition and Method8 Oct 2026US 2026/0306444 A1Provectus Pharmatech, Inc.
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Retrograde tissue splitter and method1,605US 5,449,355 AValleylab, Inc. · 1995
- Retrograde tissue splitter and method1,585US 5,797,906 AValleylab, Inc. · 1998